Abstract
Isolated ipsilateral supraclavicular (SC) lymph node recurrences of breast cancer are rare. SC recurrence is generally predictive of significant distant recurrence and rather poor prognosis. However, a curative course of systemic chemotherapy and local irradiation can be effective for patients with isolated SC recurrence, since the outcomes of patients thus treated are better than those of historical controls. This case deals with our treatment of a 44-year-old premenopausal woman with isolated contralateral SC recurrence after breast conserving surgery and sentinel lymph node (SLN) biopsy without axillary dissection for left breast cancer. The primary cancer was a triple-negative breast cancer with a tumor 7 mm in size and no metastasis in SLN. Four cycles of docetaxel and cyclophosphamide were administrated as adjuvant chemotherapy. After seven disease-free months, isolated contralateral SC lymph nodes recurred. For treatment of this recurrence, we selected eight cycles of FEC (5-fluorouracil, epirubicin, and cyclophosphamide) followed by radiation therapy for the conserved left breast and right SC fossa. Complete clinical remission has been maintained for 2 years since the recurrence. It is not known whether the treatment strategy for ipsilateral SC metastasis could have been used for our patient, but the outcome of this case suggests that systemic chemotherapy combined with local irradiation constitutes a promising option for isolated contralateral SC lymph node metastasis of breast cancer.
References
Goldhirsch A, Wood WC, Coates AS et al (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer. Ann Oncol 22:1736–1747
van der Ploeg IM, Nieweg OE, van Rijk MC et al (2008) Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 34:1277–1284
van Wely BJ, van den Wildenberg FJ, Gobardhan P et al (2012) Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 38:925–931
Estourgie SH, Nieweg OE, Olmos RA et al (2004) Lymphatic drainage patterns from the breast. Ann Surg 239:232–237
Takei H, Suemasu K, Kurosumi M et al (2007) Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer. Breast Cancer 14:16–24
Ohsumi S, Inoue T, Kiyoto S et al (2011) Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients. Breast Cancer Res Treat 130:267–272
van Rijk MC, Nieweg OE, Valdés Olmos RA et al (2005) Non-axillary breast cancer recurrences after sentinel node biopsy. J Surg Oncol 92:292–298
van der Sangen MJ, Coebergh JW, Roumen RM et al (2003) Detection, treatment, and outcome of isolated supraclavicular recurrence in 42 patients with invasive breast carcinoma. Cancer 98:11–17
van Rijk MC, Tanis PJ, Nieweg OE et al (2006) J Surg Oncol 94:281–286
Hong J, Choy E, Soni N et al (2005) Extra-axillary sentinel node biopsy in the management of early breast cancer. Eur J Surg Oncol 31:942–948
Taback B, Nguyen P, Hansen N et al (2006) Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol 13:1099–1104
Dinan D, Nagle CE, Pettinga J (2005) Lymphatic mapping and sentinel node biopsy in women with an ipsilateral second breast carcinoma and a history of breast and axillary surgery. Am J Surg 190:614–617
Pergolizzi S, Settineri N, Santacaterina A et al (2001) Ipsilateral supraclavicular lymph nodes metastases from breast cancer as only site of disseminated disease. Chemotherapy alone vs. induction chemotherapy to radical radiation therapy. Ann Oncol 12:1091–1095
Conflict of interest
Y. Miyoshi has received honoraria from Chugai Pharmaceutical Co., Ltd., AstraZeneca K.K., GlaxoSmithKline K.K., and research funding from Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd. The other authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yagi, T., Imamura, M., Hirota, S. et al. Strategy for treatment of isolated contralateral supraclavicular recurrence in patient with breast cancer after sentinel lymph node biopsy without axillary lymph node dissection. Int Canc Conf J 3, 133–139 (2014). https://doi.org/10.1007/s13691-014-0161-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13691-014-0161-y